diplopia is a well-known side effect, in common with other anti-epileptic drugs (1)
visual field defects (e.g. tunnel vision) have been reported whilst on vigabatrin therapy. The onset of the visual field defect varies from one month to several years after starting vigabatrin. Visual field loss associated with use of vigabatrin appears to be irreversible, even after cessation of therapy
Reference:
Current Problems in Pharmacovigilance (1999), 25, 13.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.